Tickle
David Tickle, Essex GB
Patent application number | Description | Published |
---|---|---|
20090023747 | Cysteine Protease Inhibitors - A compound of the formula (II) wherein one of R | 01-22-2009 |
Ian Tickle, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20080299102 | Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using - Disclosed and claimed are novel BACE proteins, crystal structures thereof, nucleic acid molecules therefor, and methods for making and using and uses of the same, especially for ascertaining inhibitors of BACE; and thus, disclosed and claimed too are inhibitors of BACE and methods of making and using the same. | 12-04-2008 |
James Tickle, Moorpark, CA US
Patent application number | Description | Published |
---|---|---|
20150060440 | FRESH FOOD SHIPPING VESSEL - A fresh food shipping Vessel is described. The food shipping Vessel includes an outer protective shell, an internal insulation cage with a closing lid and a plurality of drawers. The drawers and other components are specifically designed to provide for conductive and/or convective properties within the Vessel to assist in maintaining food items at a desired temperature. Further, the food containers and ice packs are also designed to assist in the conductive and/or convective properties of the food shipping Vessel, thereby allowing for shipment of fresh food products for extended periods of time. | 03-05-2015 |
Simon Peter Tickle, Newbury GB
Patent application number | Description | Published |
---|---|---|
20120302739 | BIOLOGICAL PRODUCTS - There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the clains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22. | 11-29-2012 |
Simon Peter Tickle, Thatcham GB
Patent application number | Description | Published |
---|---|---|
20120034656 | Neutralising Antibody Molecules Having Specificity for Human IL-17 - The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule. | 02-09-2012 |
Simon Peter Tickle, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20090117126 | Neutralising Antibody Molecules Having Specificity for Human IL-17 - The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule. | 05-07-2009 |
20090269840 | Biological Products - There are disclosed antibody molecules containing at least on CDR derived from a mouse monoclonal antibody having specificity for human KDR. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases in which VEGF and/or KDR are implicated. | 10-29-2009 |
Simon Peter Tickle, Slough GB
Patent application number | Description | Published |
---|---|---|
20100021995 | BIOLOGICAL PRODUCTS - There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22. | 01-28-2010 |
20110165659 | BIOLOGICAL PRODUCTS - There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the claims of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22. | 07-07-2011 |
20130245229 | Neutralising Antibody Molecules Having Specificity for Human IL-17 - The invention relates to an antibody molecule having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecule and methods for producing said antibody molecule. | 09-19-2013 |
Stephen Tickle, Appleton GB
Patent application number | Description | Published |
---|---|---|
20140311929 | LIQUID DOSAGE FORM AND DELIVERY SYSTEM - A pharmaceutical dosage form comprising solid liquid components comprising solid and liquid components; the solid component comprising omeprazole as active ingredient; one or more water soluble excipients; wherein the liquid component comprises: a surfactant; water and optional further excipients. | 10-23-2014 |